Published in Pharma Law Weekly, December 28th, 2004
On November 17, Biovail announced that it received notification that Anchen Pharmaceuticals, Inc., had filed an abbreviated new drug application (ANDA) for a generic formulation of Wellbutrin XL.
Chih-Ming Chen, chairman and CEO of Anchen, and Alan Cohen, chairman...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Law Weekly